High-Grade Papillary Urothelial Carcinoma: Symptoms, Risk Factors and Treatment Approaches

Bladder cancer starts when the cells lining the bladder begin growing in ways they shouldn’t. The reason it happens is different for each person, but doctors see a few patterns showing up over and over in patients who develop this disease.

Here’s what raises the risk most:

• Smoking: This is the biggest one. Nearly half of all bladder cancer cases are linked to smoking. Harmful chemicals from cigarettes get filtered out by the kidneys and pass through the bladder in urine. Over years, they slowly damage the bladder lining from the inside.
• Working with certain chemicals: People who work with dyes, rubber, leather, paint, or textiles come into contact with chemicals that are known to trigger bladder cancer. Long-term exposure adds up over time.
• Ongoing bladder problems: Long-term catheter use, frequent urinary infections, or untreated bladder stones can slowly irritate the bladder lining. That kind of constant irritation can eventually cause cell damage.
• Past cancer treatment: Some chemotherapy drugs and radiation to the lower belly area can increase bladder cancer risk years later. Ask your doctor if you’ve had either in the past.
• Age and gender: Risk rises sharply after 55. Men are three to four times more likely to develop bladder cancer than women.
• Family history: If a close family member has had bladder cancer, or if there’s a history of Lynch syndrome (a genetic condition that raises cancer risk), your own risk is higher.
• Certain infections abroad: A parasitic infection called schistosomiasis is a major cause of bladder cancer in parts of Africa and the Middle East. Not really a concern in India.

Out of all these, smoking is the one you can actually do something about. Quitting after diagnosis really does lower the chance of the cancer coming back within just two years. It’s never too late to stop.

What makes this cancer difficult to catch is how quietly it starts. Early symptoms often mimic a urinary infection or a kidney stone, and they tend to come and go. That pattern is why many patients delay seeing a specialist for months.

Watch out for the following:

• Blood in the urine, but no pain: This is the big one. About 8 out of 10 patients notice this as their first sign. The urine might look pink, brown, or almost red. Then it stops on its own, and everyone breathes a sigh of relief. That’s the trap.
• Blood picked up on a routine test: Sometimes there’s blood in the urine that you can’t actually see. A yearly checkup can catch tiny traces of it, and honestly, once you’re past 40, this becomes a lot more important than most people realise.
• Needing to pee more often than usual: Going more than 8 times during the day, or waking up two or three times at night, even when your urine tests come back completely clean.
• A sudden, urgent need to go: That “have to go, right now” feeling with almost no warning. In older patients, it often gets brushed off as a weak bladder.
• Burning while peeing: A burning feeling that just won’t go away, no matter how many rounds of antibiotics you try. Urine tests keep showing no infection, but the discomfort keeps coming back.
• Pain in the lower belly, back, or side: This usually means the cancer has moved past the early stage. Don’t sit on this one.
• Losing weight or feeling constantly tired: These are late signs. If they show up along with any of the above, it’s time to get checked without delay.

Any visible blood in urine after age 40 needs a urologist’s opinion, no matter how brief it was. These symptoms can also overlap with upper tract urothelial tumours, which start in the kidney’s drainage system or the tube connecting the kidney to the bladder rather than the bladder itself.

When the doctor suspects high-grade bladder cancer, the next few weeks are about three things: confirming it really is cancer, seeing how far it has grown, and building the right treatment plan around it. Each test picks up where the last one left off, so nothing is done just for the sake of it.

Here’s roughly how the workup unfolds:

• Cystoscopy: The doctor passes a thin flexible tube with a small camera into the bladder. It gives a clear live view of the bladder lining, and anything suspicious is sampled on the spot.
• Urine test for cancer cells: A urine sample is checked under a microscope for abnormal cells. This one’s especially useful because it can catch aggressive cancers even before there’s a visible tumour.
• TURBT (tumour removal through the urine passage): The tumour is removed without any cuts on the skin. It’s both treatment and diagnosis in one step. The tissue then goes to the lab, which reports how aggressive the cancer is and how deep it has grown.
• CT or MRI scan: A detailed scan of the kidneys, urine tubes, and bladder to check if the cancer has spread nearby or higher up in the urinary tract.
• A second TURBT after 4-6 weeks: For most aggressive T1 tumours, a second look is standard. In 30 to 50 percent of patients, leftover cancer only shows up on this second procedure.
• Bone scan or PET-CT: Only ordered in advanced cases, when the doctor suspects the cancer may have travelled to lymph nodes, lungs, liver, or bones.

Once all the reports are back, the cancer is given a stage. The stage is basically a way of describing how far it has spread, and it decides how aggressive the treatment plan needs to be.

If the cancer has already reached the bladder muscle or beyond, time genuinely matters. Even a few months of delay can shrink the treatment options and worsen the outcome. Keeping kidney function strong through this stage is just as important, since some of the chemotherapy drugs used to treat advanced disease only work well when the kidneys are in good shape.

Treatment really comes down to three things: how deep the cancer has grown, how healthy the patient is overall, and how well that first round of treatment holds. Most patients start with treatments designed to save the bladder. Bigger surgery only enters the conversation when the cancer keeps returning or begins pushing deeper into the bladder wall.

Here are the main options doctors work with:

• TURBT with BCG treatment: After the tumour is removed, a medicine called BCG is placed inside the bladder once a week for six weeks. It works by waking up the immune system so it can go after any cancer cells that were left behind.
• Chemotherapy inside the bladder: When BCG isn’t the right fit for a patient, drugs like mitomycin C are used instead. Given right after the tumour is removed, they lower the chances of the cancer coming back by around 15 to 20 percent.
• Early bladder removal surgery: If the cancer keeps returning even after BCG, removing the bladder early is often the smartest move and offers the strongest chance of long-term survival. Our post on radical cystectomy for bladder cancer walks through the surgery and recovery in full detail.
• Chemotherapy before surgery: When the cancer has already reached the bladder muscle, a round of chemotherapy given before surgery helps shrink the tumour and adds another 5 to 10 percent to 5-year survival.
• Chemotherapy or immunotherapy after surgery: If the post-surgery lab report shows the cancer had spread to nearby lymph nodes, doctors will usually add more chemotherapy or newer immunotherapy drugs to reduce the risk of it coming back.
• Long-term follow-up: Even after successful treatment, this cancer needs ongoing attention. Cystoscopies and scans are done every few months at the start, and the intervals stretch out gradually as recurrence-free time builds up.

How a patient does over the long run really depends on when the cancer was caught. If it’s still sitting on the surface of the bladder and BCG is used properly, more than 8 out of 10 patients are alive five years later.